Iterum Therapeutics (ITRM) Other Gross PP&E Adjustments (2017 - 2022)
Historic Other Gross PP&E Adjustments for Iterum Therapeutics (ITRM) over the last 6 years, with Q3 2022 value amounting to -$1.7 million.
- Iterum Therapeutics' Other Gross PP&E Adjustments rose 4414.74% to -$1.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$1.7 million, marking a year-over-year increase of 4414.74%. This contributed to the annual value of -$4.2 million for FY2021, which is 1587.62% up from last year.
- As of Q3 2022, Iterum Therapeutics' Other Gross PP&E Adjustments stood at -$1.7 million, which was up 4414.74% from -$2.2 million recorded in Q2 2022.
- In the past 5 years, Iterum Therapeutics' Other Gross PP&E Adjustments ranged from a high of $880000.0 in Q3 2018 and a low of -$9.5 million during Q1 2020
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$4.4 million (2021), whereas its average is -$4.1 million.
- As far as peak fluctuations go, Iterum Therapeutics' Other Gross PP&E Adjustments plummeted by 88924.49% in 2019, and later surged by 5158.53% in 2021.
- Over the past 5 years, Iterum Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $874000.0 in 2018, then crashed by 889.24% to -$6.9 million in 2019, then grew by 27.86% to -$5.0 million in 2020, then rose by 15.88% to -$4.2 million in 2021, then soared by 59.08% to -$1.7 million in 2022.
- Its Other Gross PP&E Adjustments was -$1.7 million in Q3 2022, compared to -$2.2 million in Q2 2022 and -$3.5 million in Q1 2022.